Startup structuring guide

Founder setup: document relationships before funding

Founder equity, vesting, IP, shareholder loans, pay and MPF are corporate-governance matters, not government programmes. This is general information only.

50verified programmes
2026-08-25Last verified
Primary sourcesGovernment, official bodies, universities and programme sites

Official facts

Amounts, durations and eligibility come from the cited primary source and carry a verification date. Intake status and terms can still change, so recheck the current guide before applying.

Editorial analysis

Suggested combinations are this site's analysis, not a government promise. Select by stage, cash flow, milestones and administrative cost.

Equity and vesting

Founder allocation should reflect long-term contribution, role, capital and departure risk.

  • Vesting or reverse vesting can address unearned shares.
  • Re-vesting, acceleration and repurchase rights need express contracts.
  • Use hypothetical Founder A / Founder B examples, never personal plans.
  • Have Hong Kong counsel review any equity structure.

IP assignment

Confirm that code, brands, patents, data and research outputs actually belong to the company.

  • A company name registration is not a trade mark right.
  • Universities, former employers, contractors and founders may hold rights.
  • Employment and contractor documents should address confidentiality, inventions and assignment.
  • Patent and trade-mark transactions can require registry updates.

Founder loans, pay and MPF

Shareholder loans and founder remuneration belong in the books with supporting documents.

  • Document principal, interest, repayment and priority; never assume a tax result.
  • Separate director fees, wages and shareholder returns.
  • Employees and self-employed persons have different MPF rules.
  • Use accounting and tax advice for related-party or cross-border transactions.

Financing and secondary

New shares and a founder sale have different cash outcomes.

  • Primary financing adds company cash and dilutes holders.
  • Founder secondary usually pays the selling holder, not the company.
  • Check consent, pre-emption, tax and disclosure before any transaction.

Official facts

Programme matrix

Compare instrument, stage, published support, equity and matching. N/A means no universal rule was published, not that there is no restriction.

High-risk amount and eligibility fields retain their verified canonical English wording so translation does not alter the rule; names, summaries and fit guidance are localized.

2 / 2
ProgrammeType / StagePublished supportEquity / MatchingBest forOfficial source
Patent Application GrantInnovation and Technology Commission

Support for eligible costs of an applicant's first patent application.

Eligibility, payment and double-funding details
Duration
N/A
Company age / eligibility
N/A
Staff requirement
N/A
Founder requirement
N/A
Payment basis
N/A
Stackability note
The grant addresses a first patent application, not general IP, legal or product-development costs.
Double funding / cash-flow restriction
Patent costs charged to another public project must be separated and checked against both schemes.
GrantMVP / Pre-seed / SeedActiveUp to HK$250,000 per approved case for the first patent applicationEquity: NoMatching: Grant covers up to 90% of eligible patent application costs, subject to the capTeams with a potentially patentable invention ready for a first filing.Official sourceLast verified: 2026-08-25
PolyU Entrepreneurship Investment FundThe Hong Kong Polytechnic University

Equity, convertible or SAFE investment in eligible PolyU ventures, with final terms set by transaction documents.

Eligibility, payment and double-funding details
Duration
N/A
Company age / eligibility
N/A
Staff requirement
N/A
Founder requirement
PolyU member ownership or PolyU intellectual property requirement applies
Payment basis
Not reimbursement based
Stackability note
Equity, convertible or SAFE instruments may be used under the programme; founders should model dilution and university IP rights.
Double funding / cash-flow restriction
This is investment, not a general grant; transaction documents govern the final structure.
InvestmentPre-seed / Seed / Early growth / Series AActiveUp to HK$4 million per company under published programme informationEquity: YesMatching: N/ACompanies with a PolyU team or IP connection that are ready for investment.Official sourceLast verified: 2026-08-25

Editorial analysis

Strategy combinations by company type

Solve the company's most real constraint first; the number of applications is not the goal.

Deep tech / Hardware / Robotics

Separate university or laboratory R&D, prototyping, trials and production-line work into distinct funding stages.

Illustrative route
Technology and IP → university/TSSSU or HKSTP → prototype and patent → ESS/RTH → public trial → smart production line → specialist VC.
Key caution
R&D, trial and production-line awards have different scopes; budget for hardware cash flow and reimbursement timing.

Biotech / HealthTech

Build the stack around university IP, laboratory access, regulation and a long R&D cycle.

Illustrative route
University IP or licence → Incu-Bio or TSSSU → RTH/ESS → validation and trials → specialist biotech capital.
Key caution
Laboratory, clinical and regulatory costs are not automatically eligible; a headline incubator amount does not replace a detailed plan.

University spin-off

Resolve IP ownership and licensing before stacking university seed support, incubation, talent and R&D funding.

Illustrative route
University IP review/licence → TSSSU or university fund → HKSTP → RTH/ESS → trial, industry partner and VC.
Key caution
Document faculty, student, university and company rights in IP and equity; funding does not automatically transfer IP.